New Fortress Energy
NFE
Workday
WDAY
DexCom
DXCM
4
Ermenegildo Zegna NV
ZGN
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
NDRA ENDRA Life Sciences
- 3.480
- -0.300-7.94%
Trading Apr 24 11:05 ET
1.96MMarket Cap-0.06P/E (TTM)
3.630High3.280Low63.02KVolume3.490Open3.780Pre Close216.42KTurnover11.21%Turnover RatioLossP/E (Static)562.21KShares664.82352wk High0.76P/B1.96MFloat Cap2.97052wk Low--Dividend TTM562.12KShs Float205800.000Historical High--Div YieldTTM9.26%Amplitude2.970Historical Low3.434Avg Price1Lot Size
ENDRA Life Sciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 22.50%-7.4M | 30.30%-1.52M | 36.23%-1.66M | 8.17%-2.08M | 14.46%-2.14M | 25.22%-9.55M | 29.60%-2.17M | 19.96%-2.6M | 31.98%-2.27M | 19.10%-2.51M |
| Net income from continuing operations | -14.39%-11.51M | -184.27%-4.15M | 24.08%-2.35M | 12.83%-2.23M | 5.68%-2.78M | 23.67%-10.06M | 55.63%-1.46M | 9.87%-3.1M | 28.79%-2.56M | -2.96%-2.94M |
| Operating gains losses | --799.28K | ---111.32K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -25.15%206.17K | -24.30%46.36K | -23.34%54.01K | -31.07%50.12K | -21.63%55.68K | 17.58%275.45K | -9.62%61.25K | 20.24%70.45K | 30.59%72.71K | 36.05%71.04K |
| Other non cash items | ---1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 114.52%134.08K | 117.75%211.13K | -229.07%-230.91K | 217.87%47.18K | -16.39%106.67K | 9.99%-923.32K | -648.17%-1.19M | 202.59%178.89K | 63.92%-40.03K | 121.94%127.58K |
| -Change in inventory | 302.88%235.73K | 10,154.20%329.48K | --0 | 719.48%138.05K | -155.75%-231.79K | 91.46%-116.19K | 69.20%-3.28K | --0 | 94.99%-22.28K | 85.96%-90.63K |
| -Change in prepaid assets | 52.91%255.91K | -70.91%36.36K | 309.15%353.87K | -0.46%-176.92K | -67.72%42.61K | -52.87%167.36K | 258.98%124.98K | 208.93%86.49K | -177.74%-176.11K | -53.94%132K |
| -Change in payables and accrued expense | 75.81%-198.87K | 90.19%-124.77K | -513.44%-540.78K | -34.14%128.97K | 175.15%337.71K | -836.96%-822.26K | -3,524.36%-1.27M | -33.85%130.8K | 40.34%195.81K | 164.40%122.74K |
| -Change in other current liabilities | -4.25%-158.7K | 24.87%-29.94K | -14.58%-43.99K | -14.58%-42.91K | -14.58%-41.86K | -15.04%-152.23K | -14.91%-39.85K | -15.08%-38.39K | -15.09%-37.45K | -15.08%-36.53K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 22.50%-7.4M | 30.30%-1.52M | 36.23%-1.66M | 8.17%-2.08M | 14.46%-2.14M | 25.22%-9.55M | 29.60%-2.17M | 19.96%-2.6M | 31.98%-2.27M | 19.10%-2.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 48.24%-12.8K | 0 | 0 | 11K | 11.87%-23.8K | 87.80%-24.72K | 105.91%2.28K | 0 | 0 | 69.78%-27K |
| Net PPE purchase and sale | 48.24%-12.8K | --0 | --0 | --11K | 11.87%-23.8K | 87.80%-24.72K | 105.91%2.28K | --0 | --0 | 69.78%-27K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 48.24%-12.8K | --0 | --0 | --11K | 11.87%-23.8K | 87.80%-24.72K | 105.91%2.28K | --0 | --0 | 69.78%-27K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3.87%7.81M | -100.00%-1 | -99.85%1.68K | 55.05%7.34M | 468.9K | -10.49%7.52M | 1.67M | 1.11M | -37.28%4.73M | 0 |
| Net issuance payments of debt | ---28.48K | --0 | --0 | --0 | ---28.48K | ---- | ---- | ---- | --0 | --0 |
| Net common stock issuance | -82.29%1.15M | --0 | --0 | -84.54%728.5K | --419.97K | -22.81%6.48M | --656.81K | --1.11M | -37.54%4.71M | --0 |
| Proceeds from stock option exercised by employees | 546.33%6.69M | -100.00%-1 | --1.68K | 32,861.80%6.61M | --77.42K | --1.03M | --1.01M | --0 | --20.05K | --0 |
| Net other financing activities | --1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3.87%7.81M | --0 | -99.85%1.68K | 55.05%7.34M | --468.9K | -10.49%7.52M | --1.67M | --1.11M | -37.28%4.73M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -42.04%2.83M | 42.30%4.75M | 32.81%6.4M | -51.82%1.13M | -42.04%2.83M | -48.33%4.89M | -58.40%3.33M | -57.27%4.82M | -66.95%2.36M | -48.33%4.89M |
| Current changes in cash | 119.25%395.57K | -202.76%-1.52M | -11.49%-1.66M | 113.70%5.27M | 32.94%-1.7M | 55.05%-2.06M | 83.99%-500.63K | 54.47%-1.48M | -40.63%2.46M | -8.55%-2.53M |
| End cash Position | 13.96%3.23M | 13.96%3.23M | 42.30%4.75M | 32.81%6.4M | -51.82%1.13M | -42.04%2.83M | -42.04%2.83M | -58.40%3.33M | -57.27%4.82M | -66.95%2.36M |
| Free cash flow | 22.60%-7.42M | 30.52%-1.52M | 36.23%-1.66M | 8.65%-2.07M | 14.31%-2.17M | 26.13%-9.58M | 30.24%-2.18M | 20.32%-2.6M | 33.17%-2.27M | 20.52%-2.53M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call